Literature DB >> 27236916

Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.

Abdul K Siraj1, Tariq Masoodi1, Rong Bu1, Shaham Beg1, Saif S Al-Sobhi2, Fouad Al-Dayel3, Mohammed Al-Dawish4, Fowzan S Alkuraya5, Khawla S Al-Kuraya6.   

Abstract

Papillary thyroid carcinoma (PTC) has a wide geographic variation in incidence; it is most common in Saudi Arabia, where it is only second to breast cancer as the most common cancer among females. Genomic profiling of PTC from Saudi Arabia has not been attempted previously. We performed whole-exome sequencing of 101 PTC samples and the corresponding genomic DNA to identify genes with recurrent somatic mutations, then sequenced these genes by using a next-generation gene-panel approach in an additional 785 samples. In addition to BRAF, N-RAS, and H-RAS, which have previously been shown to be recurrently mutated in PTC, our analysis highlights additional genes, including thyroglobulin (TG), which harbored somatic mutations in 3% of the entire cohort. Surprisingly, although TG mutations were not exclusive to mutations in the RAS-MAP kinase pathway, their presence was associated with a significantly worse clinical outcome, which suggests a pathogenic role beyond driving initial oncogenesis. Analysis of metastatic PTC tissue revealed significant enrichment for TG mutations (p < 0.001), including events of apparent clonal expansion. Our results suggest a previously unknown role of TG somatic mutations in the pathogenesis of PTC and its malignant evolution.
Copyright © 2016 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27236916      PMCID: PMC4908175          DOI: 10.1016/j.ajhg.2016.04.014

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  68 in total

1.  Activated ras oncogenes in human thyroid cancers.

Authors:  N R Lemoine; E S Mayall; F S Wyllie; C J Farr; D Hughes; R A Padua; V Thurston; E D Williams; D Wynford-Thomas
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

2.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

3.  Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.

Authors:  Peng Hou; Dingxie Liu; Yuan Shan; Shuiying Hu; Kimberley Studeman; Stephen Condouris; Yangang Wang; Ariel Trink; Adel K El-Naggar; Giovanni Tallini; Vasily Vasko; Mingzhao Xing
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

4.  Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers.

Authors:  Min S Kim; Yoo R Kim; Nam J Yoo; Sug H Lee
Journal:  APMIS       Date:  2012-07-03       Impact factor: 3.205

5.  Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

Authors:  Rafael Bejar; Kristen E Stevenson; Bennett Caughey; R Coleman Lindsley; Brenton G Mar; Petar Stojanov; Gad Getz; David P Steensma; Jerome Ritz; Robert Soiffer; Joseph H Antin; Edwin Alyea; Philippe Armand; Vincent Ho; John Koreth; Donna Neuberg; Corey S Cutler; Benjamin L Ebert
Journal:  J Clin Oncol       Date:  2014-08-04       Impact factor: 44.544

6.  PIK3CA alterations in Middle Eastern ovarian cancers.

Authors:  Jehad Abubaker; Prashant Bavi; Wael Al-Haqawi; Zeenath Jehan; Adnan Munkarah; Shahab Uddin; Khawla S Al-Kuraya
Journal:  Mol Cancer       Date:  2009-07-28       Impact factor: 27.401

7.  Gene expression signature for recurrence in stage III colorectal cancers.

Authors:  Toshiaki Watanabe; Takashi Kobunai; Etsuko Sakamoto; Yoko Yamamoto; Tsuyoshi Konishi; Atsushi Horiuchi; Ryu Shimada; Toshinori Oka; Hirokazu Nagawa
Journal:  Cancer       Date:  2009-01-15       Impact factor: 6.860

8.  Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

Authors:  Frederik Holst; Phillip R Stahl; Christian Ruiz; Olaf Hellwinkel; Zeenath Jehan; Marc Wendland; Annette Lebeau; Luigi Terracciano; Khawla Al-Kuraya; Fritz Jänicke; Guido Sauter; Ronald Simon
Journal:  Nat Genet       Date:  2007-04-08       Impact factor: 38.330

9.  Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.

Authors:  Stefanie Huhn; Melanie Bevier; Barbara Pardini; Alessio Naccarati; Ludmila Vodickova; Jan Novotny; Pavel Vodicka; Kari Hemminki; Asta Försti
Journal:  Cancer Causes Control       Date:  2014-04-05       Impact factor: 2.506

Review 10.  Controversies in papillary microcarcinoma of the thyroid.

Authors:  Monique Piersanti; Shereen Ezzat; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

View more
  23 in total

1.  Response to Yehia et al.

Authors:  Abdul K Siraj; Tariq Masoodi; Fowzan S Alkuraya; Khawla S Al-Kuraya
Journal:  Am J Hum Genet       Date:  2017-03-02       Impact factor: 11.025

2.  Thyroglobulin in Metastatic Thyroid Cancer: Culprit or Red Herring?

Authors:  Lamis Yehia; Ying Ni; Charis Eng
Journal:  Am J Hum Genet       Date:  2017-03-02       Impact factor: 11.025

3.  Mutations of genes including DNMT3A detected by next-generation sequencing in thyroid cancer.

Authors:  Ling-Chuan Guo; Wei-Dong Zhu; Xiang-Yuan Ma; Hao Ni; En-Jian Zhong; Yang W Shao; Jie Yu; Dong-Mei Gu; Shun-Dong Ji; Hao-Dong Xu; Cheng Ji; Jin-Ming Yang; Yi Zhang
Journal:  Cancer Biol Ther       Date:  2018-09-25       Impact factor: 4.742

4.  Expanding the spectrum of germline variants in cancer.

Authors:  Abdul K Siraj; Tariq Masoodi; Rong Bu; Sandeep Kumar Parvathareddy; Ismail A Al-Badawi; Nasser Al-Sanea; Luai H Ashari; Alaa Abduljabbar; Samar Alhomoud; Saif S Al-Sobhi; Asma Tulbah; Dahish Ajarim; Khalid Alzoman; Muna Aljuboury; Hussam Bin Yousef; Mohammed Al-Dawish; Fouad Al-Dayel; Fowzan S Alkuraya; Khawla S Al-Kuraya
Journal:  Hum Genet       Date:  2017-10-03       Impact factor: 4.132

5.  Evolution and Impact of Subclonal Mutations in Papillary Thyroid Cancer.

Authors:  Tariq Masoodi; Abdul K Siraj; Sarah Siraj; Saud Azam; Zeeshan Qadri; Sandeep K Parvathareddy; Saif S Al-Sobhi; Mohammed AlDawish; Fowzan S Alkuraya; Khawla S Al-Kuraya
Journal:  Am J Hum Genet       Date:  2019-10-24       Impact factor: 11.025

6.  Integrating omics data and protein interaction networks to prioritize driver genes in cancer.

Authors:  Tiejun Zhang; Di Zhang
Journal:  Oncotarget       Date:  2017-07-22

7.  Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.

Authors:  Tingyue Qi; Xin Rong; Qingling Feng; Hongguang Sun; Haiyan Cao; Yan Yang; Hao Feng; Linhai Zhu; Lei Wang; Qiu Du
Journal:  Int J Med Sci       Date:  2021-04-26       Impact factor: 3.738

Review 8.  Refractory thyroid carcinoma: which systemic treatment to use?

Authors:  Laurence Faugeras; Anne-Sophie Pirson; Julian Donckier; Luc Michel; Julien Lemaire; Sebastien Vandervorst; Lionel D'Hondt
Journal:  Ther Adv Med Oncol       Date:  2018-01-23       Impact factor: 8.168

9.  MED12 is recurrently mutated in Middle Eastern colorectal cancer.

Authors:  Abdul K Siraj; Tariq Masoodi; Rong Bu; Poyil Pratheeshkumar; Nasser Al-Sanea; Luai H Ashari; Alaa Abduljabbar; Samar Alhomoud; Fouad Al-Dayel; Fowzan S Alkuraya; Khawla S Al-Kuraya
Journal:  Gut       Date:  2017-02-09       Impact factor: 23.059

10.  Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.

Authors:  Seung-Hyun Jung; Min Sung Kim; Chan Kwon Jung; Hyun-Chun Park; So Youn Kim; Jieying Liu; Ja-Seong Bae; Sung Hak Lee; Tae-Min Kim; Sug Hyung Lee; Yeun-Jun Chung
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.